Pharmacokinetics of D(+)-usnic Acid in Rabbits After Intravenous and Oral Administration
Overview
Authors
Affiliations
The pharmacokinetics of D(+)-usnic acid--a lichen antitubercular, antitumor, and enzyme-inhibiting agent--was studied in rabbits following intravenous or oral administration of 5 and 20 mg/kg body weight doses, respectively. Plasma samples were collected at different time intervals, and usnic acid was determined by HPLC. Plasma usnic acid levels following intravenous administration showed a triexponential elimination with a mean +/- SD terminal half-life of 10.7 +/- 4.6 hr. The volume of distribution of the central compartment and systemic clearance were 43.9 +/- 21.3 ml/kg and 12.2 +/- 3.0 ml/hr/kg, respectively. Pharmacokinetic parameters obtained, based on compartmental and noncompartmental approaches, were comparable. Plasma concentration data obtained after oral administration were analyzed using a noncompartmental method. Peak plasma level (Cmax) of 32.5 +/- 6.8 micrograms/ml was achieved in 12.2 +/- 3.8 hr (tmax). Mean absolute bioavailability of usnic acid following oral administration was 77.8%.
Multifaceted Properties of Usnic Acid in Disrupting Cancer Hallmarks.
Gimla M, Herman-Antosiewicz A Biomedicines. 2024; 12(10).
PMID: 39457512 PMC: 11505503. DOI: 10.3390/biomedicines12102199.
Wang H, Xuan M, Huang C, Wang C Molecules. 2022; 27(21).
PMID: 36364296 PMC: 9657990. DOI: 10.3390/molecules27217469.
Toxicity of Usnic Acid: A Narrative Review.
Croce N, Pitaro M, Gallo V, Antonini G J Toxicol. 2022; 2022:8244340.
PMID: 36310641 PMC: 9605823. DOI: 10.1155/2022/8244340.
Biochemical Properties of Atranorin-Induced Behavioral and Systematic Changes of Laboratory Rats.
Simko P, Leskanicova A, Suvakova M, Blicharova A, Karasova M, Goga M Life (Basel). 2022; 12(7).
PMID: 35888178 PMC: 9316313. DOI: 10.3390/life12071090.
Nikolin V, Popova N, Kaledin V, Luzina O, Zakharenko A, Salakhutdinov N Clin Exp Metastasis. 2021; 38(5):431-440.
PMID: 34370156 DOI: 10.1007/s10585-021-10113-y.